Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
+531K
-
Total reported value, excl. options
-
$223M
-
Value change
-
+$9.84M
-
Number of buys
-
9
-
Number of sells
-
-6
-
Price
-
$18.55
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2016
26 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2016.
Ascendis Pharma A/S - ADR (ASND) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 55.6M outstanding shares and own 21.66% of the company stock.
Largest 10 shareholders include FMR LLC (2.3M shares), RA CAPITAL MANAGEMENT, LLC (2.16M shares), Vivo Capital, LLC (1.42M shares), Visium Asset Management, LP (1.41M shares), RS INVESTMENT MANAGEMENT CO LLC (986K shares), VHCP Management II, LLC (721K shares), JANUS CAPITAL MANAGEMENT LLC (670K shares), ACUTA CAPITAL PARTNERS, LLC (624K shares), BAKER BROS. ADVISORS LP (506K shares), and Rock Springs Capital Management LP (270K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.